GAMCO Investors’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

GAMCO Investors’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-48,099	Closed	-$914K	–	964
2019 Q1	$914K	Sell	48,099 -21,900	-31%	-$355K	0.01%	594
2018 Q4	$945K	Hold	69,999	–	–	0.01%	549
2018 Q3	$777K	Buy	+69,999	New	+$700K	0.01%	611

Other funds holding OSIR

FGAM

Financial Gravity Asset Management Lakeway, Texas $562M AUM

GAMCO Investors's OSIR Position: Q2 2019 in Review

GAMCO Investors sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 48,099 shares — an estimated $914K sold.

GAMCO Investors first reported a position in OSIR in Q3 2018 and held it in 3 quarters. The position peaked at $945K in Q4 2018. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

GAMCO Investors reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
GAMCO Investors sold 48,099 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $914K.
GAMCO Investors first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2018 and held it in 3 quarters.
GAMCO Investors's Osiris Therapeutics, Inc. Common Stock position peaked at $945K in Q4 2018.
1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on GAMCO Investors's 13F filing for Q2 2019, filed 2 Aug 2019.